XiFin joins Future of Pharmacy Care Coalition
Healthcare technology leader expands advocacy efforts supporting pharmacist clinical services, reimbursement modernization, and patient access initiatives.
Healthcare technology leader expands advocacy efforts supporting pharmacist clinical services, reimbursement modernization, and patient access initiatives.
New facility at Community Care of West Virginia’s Clarksburg location offers health and wellness resources, community meeting space and member support
Frazier addressed graduates from LIU Brooklyn, LIU Hudson, LIU Global, and the College of Pharmacy during the University's Centennial Commencement celebration marking 100 years since LIU's founding in 1926.
Dr. Reddy’s is the first company to receive Health Canada approval for generic Semaglutide Injection in Canada.
The retail giant is turning former pharmacy locations into rapid-delivery hubs as it expands grocery fulfillment operations.
Independent businesses and farmers unveil affordability agenda centered on stronger competition policy and antitrust enforcement.
New program helps reduce financial barriers to higher education while building a stronger, more robust pharmacy workforce.
Omnicare will continue to support its clients with transparent pricing, clinically aligned programs and data‑driven insights, as well as a partnership‑driven approach for all communities it serves.
The Patients Before Monopolies Act aims squarely at the conflicts of interest created by vertically integrated PBMs by prohibiting a parent company from owning both a PBM/health insurer and a pharmacy,
In-person and virtual services support chronic disease prevention and long-term metabolic health.
New direct-to-consumer site provides physician-reviewed access to compounded semaglutide and tirzepatide, delivered to patients’ doors.
An order issued Monday by Justice Samuel Alito keeps existing access in place until at least Thursday, allowing the pill to continue to be obtained at pharmacies or by mail without an in‑person doctor visit.
Reports that President Trump approved plans to remove FDA Commissioner Marty Makary have fueled uncertainty around the agency as disputes over vaping, abortion pills and drug approvals intensify.
Makary’s departure would mark the latest shakeup among top federal health officials under the Trump administration.
Trump announced the move after Means’ nomination stalled in the Senate, where lawmakers from both parties raised concerns about her experience, her lack of an active medical license, and her positions on vaccines.
This reaccreditation reflects Walgreens Specialty Pharmacy’s continued focus on delivering high‑quality care for patients managing complex and chronic conditions.